Open AccessRandomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease
Author(s) -
David E. Kandzari,
Pieter C. Smits,
Michael P. Love,
Ori BenYehuda,
Shmuel Banai,
Simon D. Robinson,
Michael Jonas,
Ran Kornowski,
Rodrigo Bagur,
Andrés Íñiguez,
Haim Danenberg,
Robert Feldman,
Rajiv Jauhar,
Harish Chandna,
Manish Parikh,
Gidon Perlman,
Mercedes Balcells,
Peter Markham,
Melek Ozgu Ozan,
Philippe Généreux,
Elazer R. Edelman,
Martin B. Leon,
Gregg W. Stone
Publication year - 2017
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.117.028885
Subject(s) - medicine , zotarolimus , cardiology , coronary artery disease , randomized controlled trial , stent , restenosis , drug eluting stent
The safety and efficacy of a novel cobalt alloy-based coronary stent with a durable elastomeric polymer eluting the antiproliferative agent ridaforolimus for treatment of patients with coronary artery disease is undetermined.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom